India to Malta: Vinorelbine Export Trade Route

The India to Malta Vinorelbine corridor is one of India's established pharmaceutical export routes, with 24 shipments documented worth a combined $776.6K USD. The route is dominated by EUGIA PHARMA SPECIALITIES LIMITED, which alone accounts for roughly 78% of all export value, reflecting the consolidated nature of India's vinorelbine manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $32.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with vinorelbine's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 10.3%, placing it at rank #3 among India's top vinorelbine export destinations globally.

On the import side, key buyers of Indian vinorelbine in Malta include EUGIA PHARMA (MALTA) LTD,, EUGIA PHARMA (MALTA) LTD, , EUGIA PHARMA (MALTA) LIMITED, and 6 others. EUGIA PHARMA (MALTA) LTD, is the single largest importer with 9 shipments valued at $247.2K USD.

India's vinorelbine exports to Malta are driven primarily by a handful of large-scale manufacturers. EUGIA PHARMA SPECIALITIES LIMITED with 19 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Malta benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $32.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as vinorelbine tartrate 10 mg/ml for infusi and vinorelbine injection 50 mg / 5ml (10 mg/ ml) (vinorelbine tartrate concentrated solution for infusion 10 mg/ml (50 mg/5vls, suggesting that buyers in Malta tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, EUGIA PHARMA (MALTA) LTD, is the largest importer with 9 shipments worth $247.2K USD — representing 32% of all vinorelbine imports from India on this route. A total of 9 buyers are active on this corridor.